Results 111 to 120 of about 1,955 (161)
Some of the next articles are maybe not open access.

Dantrolene

Drugs, 2012
Eugene M Sorkin, E M Sorkin
exaly   +2 more sources

Dantrolene : From Malignant Hyperthermia to Alzheimer’s Disease

open access: yesCNS and Neurological Disorders - Drug Targets, 2020
Dantrolene, a ryanodine receptor antagonist, is primarily known as the only clinically acceptable and effective treatment for Malignant Hyperthermia (MH).
Huafeng Wei
exaly   +2 more sources

Dantrolene requires Mg 2+ to arrest malignant hyperthermia

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2017
Malignant hyperthermia (MH) is a clinical syndrome of skeletal muscle that presents as a hypermetabolic response to volatile anesthetic gases, where susceptible persons may develop lethally high body temperatures.
Xaver Koenig, Bradley Launikonis
exaly   +3 more sources

Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines

open access: yesBritish Journal of Anaesthesia, 2020
Faced with a malignant hyperthermia crisis, the immediate access to sufficient dantrolene is essential to achieve the best possible outcome for the patient.
Stephan Johannsen, Thierry Girard
exaly   +2 more sources

Dantrolene and suxamethonium

Anaesthesia, 1979
A single oral dose of dantrolene (100--150 mg) given at least 2 hr pre-operatively has been found to reduce significantly the strength of muscular fasciculations, the hyperkalaemia and the incidence of muscle pains following suxamethonium (from 56 to 4%) in a series of forty-eight patients compared with controls.
openaire   +2 more sources

Hyperkalemia after Dantrolene and Verapamil-Dantrolene Administration in Dogs

Anesthesia & Analgesia, 1988
The concurrent administration of dantrolene and verapamil has the theoretical advantage of being more efficacious than dantrolene alone in the treatment of malignant hyperthermia. However, the combination has been reported to cause fatal hyperkalemia in pigs.
A C, San Juan, K C, Wong, J D, Port
openaire   +2 more sources

Dantrolene

Reactions Weekly, 2021
openaire   +2 more sources

Dantrolene and “ecstasy”

Medical Journal of Australia, 1997
M A, Denborough, K C, Hopkinson
openaire   +2 more sources

Dantrolene

Reactions Weekly, 2016
  +4 more sources

Dantrolene

Reactions Weekly, 2022
openaire   +2 more sources

Home - About - Disclaimer - Privacy